#adolescent

A new global alliance launches to end AIDS in children by 2030. Currently, only half of children with HIV are on lifesaving treatment.

After a long wait, the FDA authorizes Pfizer and Moderna vaccines for children as young as 6 months old.

The long-acting regimen will enable some adolescents to take their HIV treatment just six times a year.

Intensive lifestyle management led to weight loss and reduced steatosis and fibrosis.

The American Academy of Pediatrics recommends HIV testing for youth ages 15 and older. Updated guidance now includes PrEP and PEP.

Hospital-diagnosed infections of youth between ages 11 and 19 are associated with an elevated risk of developing MS.

Younger adults and stem cell transplant recipients are at highest risk for measles and mumps.

Little HIV prevention research has included pregnant women for fear of adverse birth outcomes.

Immigrants and girls had worse HIV outcomes in this study.

Authorization of the vaccine adds nearly 17 million more Americans to the pool of those eligible to be immunized against COVID-19.

The Pfizer-BioNTech vaccine was 100% effective in a study of adolescents; trials for younger children are now underway.

Study also finds that trans girls are more likely to receive gender-affirming care than trans boys.

Compared with efavirenz-based regimens, dolutegravir-containing ones resulted in fewer switches and better viral control.

Maryland proposes a somewhat novel concept: mental health days for high school students.

To protect African Americans’ future heart health, doctors should begin monitoring individuals’ blood pressure when adolescence begins.

Despite progress, adolescents and young adults face substantial cancer disparities by race/ethnicity.